Novo Nordisk A/S ADR buy TD Cowen
Start price
03.02.26
/
50%
€48.60
Target price
03.02.27
-
Performance (%)
-17.90%
Price
06.08.26
€39.90
Summary
This prediction is currently active. The price of Novo Nordisk A/S ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.90%. This prediction currently runs until 03.02.27. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -10.818% | -10.818% |
| iShares Core DAX® | 3.153% | 1.504% |
| iShares Nasdaq 100 | 7.431% | -1.584% |
| iShares Nikkei 225® | 8.571% | -4.324% |
| iShares S&P 500 | 4.578% | 1.920% |
Comments by TD_Cowen for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for NVO provided by MarketBeat
Stopped prediction by TD_Cowen for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.20
19.08.25
19.08.25
€60.08
19.08.26
19.08.26
-15.47%
06.08.26
06.08.26
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€93.00
04.12.23
04.12.23
€106.28
04.12.24
04.12.24
11.83%
05.12.24
05.12.24